Effect of SNAGs and Scapular Mobilizations in Patients With Scapulocostal Syndrome

NCT ID: NCT06656182

Last Updated: 2024-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the impact of SNAGs and Scapular mobilizations on pain, cervical and shoulder Range of motion and functional outcomes in individuals with Scapulocostal Syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The rationale for employing SNAGS (Sustained Natural Apophyseal Glides) in treating scapulocostal syndrome is multifaceted. By targeting specific joint surfaces and soft tissue structures, SNAGS aim to address joint dysfunction, alleviate pain, and improve mobility in the scapulothoracic region. These sustained gliding movements not only modulate pain signals but also promote relaxation and reduce muscle tension, thereby enhancing the effectiveness of therapeutic exercises aimed at strengthening the surrounding musculature. Additionally, SNAGS facilitate proper muscle activation patterns, optimizing muscle function and coordination. Their adaptability allows for a patient-centered approach, ensuring tailored treatment that considers individual symptoms, mobility deficits, and treatment goals, ultimately promoting better functional outcomes in individuals with scapulocostal syndrome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scapulocostal Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervical and Thoracic SNAGs

Cervical and Thoracic SNAGs with 6 reps and 1 set along with cervical and shoulder muscle stretching and scapular mobilizations

Group Type EXPERIMENTAL

Cervical and Thoracic SNAGs

Intervention Type OTHER

cervical SNAGs (C3-C7) and thoracic SNAGs (T1-T12) with 6 repetitions of 1 set three times per week for 4 weeks along with scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)

traditional physical therapy and scapular mobilizations

cervical and shoulder muscle stretching and scapular mobilizations

Group Type ACTIVE_COMPARATOR

traditional physical therapy and scapular mobilizations

Intervention Type OTHER

scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cervical and Thoracic SNAGs

cervical SNAGs (C3-C7) and thoracic SNAGs (T1-T12) with 6 repetitions of 1 set three times per week for 4 weeks along with scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)

Intervention Type OTHER

traditional physical therapy and scapular mobilizations

scapular mobilizations of 10 repetitions of 1 set and stretching of trapezius (upper, middle and lower fibers), levator scapulae and rhomboids (major and minor)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age- 18 to 40 years.

* Male and female both
* Nonspecific neck pain with a duration of greater than 3 months
* No pain reproduction on isometric muscle testing in shoulder.
* Patients who could not achieve 60 degrees of upward rotation when elevating the arms above the head i.e. presence of scapular dyskinesia
* pain with a referral pattern while receiving manual pressure of at least 3 points on the medial scapular muscles (levator scapulae, rhomboid major, rhomboid minor, and serratus posterior superior) evaluated through Travels and Simon criteria.
* Discomfort, pain, or limitations in neck extension, neck rotation bilaterally, shoulder forward flexion, shoulder abduction attributed to SCS.
* Willing to provide informed consent to participate in the study.

Exclusion Criteria

* Musculoskeletal pathologies affecting the cervical spine or lower extremities (e.g., herniated disc, cervical radiculopathy, cervical stenosis, shoulder labral tear).

* history of degenerative shoulder joint disease
* rotator cuff dysfunction
* Thoracic outlet syndrome
* Brachial neuralgia
* shoulder impingement syndrome
* adhesive capsulitis
* Pregnant individuals due to potential discomfort.
* Open wounds, infections, or skin conditions at pain site.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Asmar Fatima, MS-PT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DSK physio and Rehab Center

Rawalpindi, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Asmar Fatima, MS-OMPT

Role: CONTACT

03336195644

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Asmar Fatima, MS-OMPT

Role: primary

03336195644

Rabia Asif, MS_OMPT*

Role: backup

03335193218

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/MS-PT/01941 Rabia Asif

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.